News
![Eve Sleep plc: Trading update](/assets/news/news2-a19c21d90ec8043c932052617f43da76ea8e48ecd096318e237ea24d69a5c8b8.png)
Eve Sleep plc: Trading update
Eve Sleep plc: Trading update
![Eve Sleep plc: Total Voting Rights](/assets/news/news19-14feaf1b3ac689101974b5354f2ab8bb5cb2e7cb49a06b120b8491e9ebba31f4.png)
Eve Sleep plc: Total Voting Rights
Eve Sleep plc: Total Voting Rights
![Form 8.3 - Tibra Trading PTY Limited: SUMO GROUP PLC](/assets/news/news17-d49b9ce9c87babddea210274f0f8d00a1cf706146ef6382020cc7ece83b76f6c.png)
Form 8.3 - Tibra Trading PTY Limited: SUMO GROUP PLC
Form 8.3 - Tibra Trading PTY Limited: SUMO GROUP PLC
![Form 8.3 - Tibra Trading PTY Limited: SUMO GROUP PLC](/assets/news/news18-f135f6c168ef56d2b112890081403b0a310104acfadbf4a8f72634bd390e98ac.png)
Form 8.3 - Tibra Trading PTY Limited: SUMO GROUP PLC
Form 8.3 - Tibra Trading PTY Limited: SUMO GROUP PLC
![Form 8.3 - Tibra Trading PTY Limited: SUMO GROUP PLC](/assets/news/news14-e52b56a6adda780de8ab40d75cabe14dcfa77fc9676e986401297a29e68c991e.png)
Form 8.3 - Tibra Trading PTY Limited: SUMO GROUP PLC
Form 8.3 - Tibra Trading PTY Limited: SUMO GROUP PLC
![Form 8.3 - Tibra Trading PTY Limited: SUMO GROUP PLC](/assets/news/news12-a6c8e663da6f66e4f8b76885d84b91bc276bfd92fd8727e9ade1f1d9f4df9b67.png)
Form 8.3 - Tibra Trading PTY Limited: SUMO GROUP PLC
Form 8.3 - Tibra Trading PTY Limited: SUMO GROUP PLC
![Form 8.3 - Tibra Trading PTY Limited: SUMO GROUP PLC](/assets/news/news9-b4ba75b613b80e3d047ded18f34335e7f81348578b67aee3f1469440916c031e.png)
Form 8.3 - Tibra Trading PTY Limited: SUMO GROUP PLC
Form 8.3 - Tibra Trading PTY Limited: SUMO GROUP PLC
![CentralNic Group (CNIC): A scaling player in online services](/assets/news/news16-82a218458f0e15ae617f9186b258dfd3add112716106c6ee3cbb48563ccdef52.png)
CentralNic Group (CNIC): A scaling player in online services
CentralNic Group (CNIC): A scaling player in online services
![Form 8.3 - Tibra Trading PTY Limited: SUMO GROUP PLC](/assets/news/news15-207f60e93f55a63563671c62b1e07d0bc426e50a03c286a608f29c8138f4f1de.png)
Form 8.3 - Tibra Trading PTY Limited: SUMO GROUP PLC
Form 8.3 - Tibra Trading PTY Limited: SUMO GROUP PLC
![ADC Therapeutics gibt freiwillige Unterbrechung der Aufnahme in die klinische Phase-II-Studie LOTIS-9 zu ZYNLONTA® (Loncastuximab-Tesirin-Lpyl) und Rituximab bei nicht fitten oder gebrechlichen, zuvor unbehandelten DLBCL-Patienten bekannt](/assets/news/news12-a6c8e663da6f66e4f8b76885d84b91bc276bfd92fd8727e9ade1f1d9f4df9b67.png)
ADC Therapeutics gibt freiwillige Unterbrechung der Aufnahme in die klinische Phase-II-Studie LOTIS-9 zu ZYNLONTA® (Loncastuximab-Tesirin-Lpyl) und Rituximab bei nicht fitten oder gebrechlichen, zuvor unbehandelten DLBCL-Patienten bekannt
LAUSANNE, Schweiz, July 12, 2023 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) hat heute eine freiwillige Unterbrechung der Aufnahme neuer Patienten in die klinische Phase-II-Studie LOTIS-9